myristicin has been researched along with Diabetes Mellitus, Type 2 in 1 studies
myristicin: asaricin is an isomer; structure; a methylene dioxy version of elemicin;
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brindis, F | 1 |
| Rodríguez, R | 1 |
| Bye, R | 1 |
| González-Andrade, M | 1 |
| Mata, R | 1 |
1 other study available for myristicin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
Topics: Acarbose; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Me | 2011 |